错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma

  • Daniel H. Shu,
  • Won Jin Ho,
  • Luciane T. Kagohara,
  • Alexander Girgis,
  • Sarah M. Shin,
  • Ludmila Danilova,
  • Jae W. Lee,
  • Dimitrios N. Sidiropoulos,
  • Sarah Mitchell,
  • Kabeer Munjal,
  • Kathryn Howe,
  • Kayla J. Bendinelli,
  • Emma Kartalia,
  • Hanfei Qi,
  • Guanglan Mo,
  • Janelle Montagne,
  • James M. Leatherman,
  • Tamara Y. Lopez-Vidal,
  • Qingfeng Zhu,
  • Amanda L. Huff,
  • Xuan Yuan,
  • Alexei Hernandez,
  • Erin M. Coyne,
  • Neeha Zaidi,
  • Daniel J. Zabransky,
  • Logan L. Engle,
  • Aleksandra Ogurtsova,
  • Marina Baretti,
  • Daniel Laheru,
  • Jennifer N. Durham,
  • Hao Wang,
  • Joel C. Sunshine,
  • Robert J. Johnston,
  • Julie Stein Deutsch,
  • Janis M. Taube,
  • Robert A. Anders,
  • Elizabeth M. Jaffee,
  • Elana J. Fertig,
  • Mark Yarchoan

摘要

Tertiary lymphoid structures (TLS) are associated with improved response in solid tumors treated with immune checkpoint blockade, but understanding of the prognostic and predictive value of TLS and the circumstances of their resolution is incomplete. Here we show that in hepatocellular carcinoma treated with neoadjuvant immunotherapy, high intratumoral TLS density at the time of surgery is associated with pathologic response and improved relapse-free survival. In areas of tumor regression, we identify a noncanonical involuted morphology of TLS marked by dispersion of the B cell follicle, persistence of a T cell zone enriched for T cell–mature dendritic cell interactions and increased expression of T cell memory markers. Collectively, these data suggest that TLS can serve as both a prognostic and predictive marker of response to immunotherapy in hepatocellular carcinoma and that late-stage TLS may support T cell memory formation after elimination of a viable tumor.